Literature DB >> 6023140

Propranolol-induced depression.

J D Fitzgerald.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6023140      PMCID: PMC1841746          DOI: 10.1136/bmj.2.5548.372-b

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  4 in total

1.  Effect of propranolol in mild hypertension.

Authors:  J W Paterson; C T Dollery
Journal:  Lancet       Date:  1966-11-26       Impact factor: 79.321

2.  The treatment of hypertension by beta adrenergic blocking drugs.

Authors:  B N Prichard
Journal:  Angiologica       Date:  1966

3.  Propranolol in hypertension.

Authors:  F A Richards
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

4.  USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION.

Authors:  B N PRICHARD; P M GILLAM
Journal:  Br Med J       Date:  1964-09-19
  4 in total
  6 in total

1.  Anxiety and depression symptoms in arterial hypertension: the influence of antihypertensive treatment. the HUNT study, Norway.

Authors:  Aslak Johansen; Jostein Holmen; Robert Stewart; Ottar Bjerkeset
Journal:  Eur J Epidemiol       Date:  2011-12-20       Impact factor: 8.082

Review 2.  Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.

Authors:  D J Greenblatt; J Koch-Weser
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 3.  Use of beta-adrenergic receptor blocking drugs in psychiatry.

Authors:  F A Whitlock; J Price
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 4.  Drug-induced psychiatric disorders and their management.

Authors:  L E Hollister
Journal:  Med Toxicol       Date:  1986 Nov-Dec

5.  General medical with depression drugs associated.

Authors:  Donald Rogers; Ronald Pies
Journal:  Psychiatry (Edgmont)       Date:  2008-12

Review 6.  Neuropsychiatric consequences of cardiovascular medications.

Authors:  Jeff C Huffman; Theodore A Stern
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.